GENEMEDICS APP
GENEMEDICS NUTRITION
Vitamin D, also known as cholecalciferol (vitamin D3), ergocalciferol (Vitamin D2), or the sunshine vitamin, is one of the 24 micronutrients critical for human survival. In spite of the name, vitamin D is often referred to as a pro-hormone because the body is capable of producing its own vitamin D through mild sun exposure, while vitamins are nutrients that cannot be produced by the body and must be acquired by eating vitamin-rich foods or taking supplements.
It is estimated that sensible sun exposure on bare skin for 5-10 minutes twice or thrice a week allows the body to produce adequate amounts of vitamin D. However, this vitamin has a half-life of only 2 weeks, meaning that vitamin D stores can be depleted. Recent studies have suggested that vitamin D deficiency affects almost 50% of adults and children worldwide. [252] Because of the extensive benefits of vitamin D for human health, the United States Department of Agriculture (USDA) recently increased the recommended daily allowance for vitamin D for adults and the American Academy of Pediatrics recommends that children get adequate vitamin D.
The following are the recommended intakes of vitamin D throughout life: [253]
There are certain medical conditions and factors that can cause a deficiency in vitamin D. These include the following:
In men and women with vitamin D deficiency, the symptoms are generally subtle so they may not notice them easily, even if it’s having a significant impact in their quality of life. The common signs and symptoms of vitamin D deficiency are the following:
If you are suffering from symptoms of vitamin D deficiency, it is recommended to consult immediately with your doctor to get your vitamin D levels checked. A detailed physical examination will also help rule out any medical conditions, risk factors for vitamin D deficiency, and other factors that may affect vitamin D levels. If left untreated, severely low levels of vitamin D can lead to osteomalacia in adults, and rickets in children. Both of these diseases can lead to soft and weak bones, bone and muscle pain, and higher incidence of fractures.
Sunlight is the most cost effective way of boosting vitamin D stores. However, for people living in northern latitudes and for dark-skinned people, getting adequate amounts of vitamin D through sun exposure can be a problem. Fortunately, they can still load up on this vitamin by consuming the following foods:
Aside from diet and sun exposure, vitamin D supplements in the form of capsules, tablets, and intramuscular injections may be necessary for older people, those living in northern latitudes, dark-skinned people, obese individuals, post bariatric surgery patients, people on vitamin D-depleting medications, and those with medical conditions that affect vitamin D levels. In fact, there is a great body of clinical evidence that shows the diverse health benefits of vitamin D in both men and women:
Vitamin D is extremely important for regulating the growth of billions of cells, enhancing their communication, and modulating general cellular function. Aside from these roles, vitamin D also has potent anti-cancer properties that can help eradicate malignant cells in the body. There is very strong clinical evidence that vitamin D supplementation may help protect against various types of cancers in both men and women:
Vitamin D plays a major role in the regulation of the immune function by turning on or off genes and processes necessary for optimum health. In fact, vitamin D is touted as a “miracle nutrient” for the immune system as it enables the body to produce hundreds of antimicrobial peptides, which helps ward off various infections and diseases. An overwhelming body of clinical evidence supports the immune-modulating properties of vitamin D:
Cognitive dysfunction can lead to confusion, memory problems, and difficulty concentrating. Interestingly, scientists found that vitamin D can function as a neurosteroid or “cognitive enhancer”, thus preventing age-related cognitive decline and improving overall mental health. A growing body of scientific evidence supports the brain-boosting properties of vitamin D:
Muscle mass and strength tend to decrease with advancing age, primarily as a result of reduced physical activity. This loss of muscle mass, medically known as sarcopenia, has negative impact on one’s ability to perform activities of daily living. Fortunately, vitamin D supplementation may be an effective method of countering age-related muscle wasting and those caused by chronic medical conditions. There is an overwhelming body of clinical research supporting the muscle-enhancing properties of vitamin D:
Vitamin D plays a major role in improving bone strength and quality. Without the “sunshine vitamin”, our bodies cannot effectively absorb calcium and phosphorus – two key nutrients in bone growth and development. There is increasing evidence that vitamin D supplementation may help improve bone health in the older population as well as those with medical conditions affecting the bones:
A healthy brain is the first line of defense against mental health problems including depression. Since vitamin D plays major role in brain health throughout all stages of life, boosting its levels may help increase energy levels and improve overall mood. Several lines of evidence support the antidepressant effect of vitamin D:
Vitamin D is believed to help lower blood sugar levels as well as diabetes risk by improving the body’s response to the effects of insulin – the hormone that regulates blood sugar levels. Of further interest, vitamin D status is associated with blood sugar levels, suggesting that restoration of vitamin D to healthy levels may have beneficial effects. An overwhelming body of clinical research supports the anti-diabetic properties of vitamin D:
High blood pressure, medically known as hypertension, can significantly increase one’s risk of developing chronic, debilitating medical conditions such as heart disease, diabetes, stroke, and other fatal diseases. By reducing blood pressure, the risk of getting these diseases also decreases. There is strong scientific evidence that vitamin D has potent anti-hypertensive properties that can help ward off diseases associated with high blood pressure:
Just like hypertension and high blood sugar, elevated cholesterol levels can significantly increase one’s risk of developing fatal medical conditions. Fortunately, sun exposure and a high vitamin D diet can be a cost-effective way to bring down cholesterol levels within normal range. In fact, several lines of evidence support the cholesterol-lowering effect of vitamin D:
Vitamin D is also known as an anti-obesity nutrient, which is essential in maintaining a healthy weight. Several research studies found that the sunshine vitamin can help overweight and obese people lose weight safely and effectively:
Vitamin D can also help reverse heart damage and protect against cardiovascular diseases. Because it has beneficial effects on various cardiovascular parameters such as blood pressure, blood sugar, and cholesterol levels, vitamin D can be an important nutrient for the maintenance of a healthy heart. A growing number of studies support the cardiovascular effects of vitamin D:
Vitamin D levels are directly related to sleep quantity and quality. Therefore, boosting vitamin D levels through sun exposure, diet and supplements may have benefical effects on sleep. In fact, several high quality studies suggest that vitamin D has positive effects on age-related sleeping difficulties as well as sleeping disorders:
There is a fascinating relationship between vitamin D and the kidneys. Whether from supplements or from the sun, the kidneys help convert vitamin D into its active form so that it can be effectively used by the body. Newer research shows that vitamin D may play a protective role against kidney disorders and keeping the kidneys working at optimum levels:
With advancing age, sexual dysfunction occurs, resulting in decreased self-confidence and quality of life. Fortunately, vitamin D supplementation is one of the most cost-effective ways of ramping up sexual power in both men and women. There is accumulating evidence that vitamin D can help increase libido and restore sexual function while improving overall health:
Vitamin D also plays an integral part in reproduction. In women, vitamin D supplementation can drastically increase pregnancy sucesss rate. In men, loading up on vitamin D has beneficial effects on sperm quality and quantity. A growing body of clinical evidence supports the many benefits of vitamin D on various fertility markers:
Hair loss is inevitable and occurs with advancing age or it can be caused by other medical conditions. Aside from having a negative physical impact, hair loss often comes with devastating psychological consequences. Recently, medical professionals found a long-term, cost-effective solution to hair loss, thus eliminating the need for expensive medications and hair transplantation. Studies show that vitamin D supplementation alone can help fight hair loss:
Garland CF, Garland FC, Gorham ED, et al. The Role of Vitamin D in Cancer Prevention. American Journal of Public Health. 2006;96(2):252-261. doi:10.2105/AJPH.2004.045260.
The Role of Vitamin D in Cancer Prevention
The study “The Role of Vitamin D in Cancer Prevention” by Garland CF, Garland FC, Gorham ED, et al., published in the American Journal of Public Health in 2006, examines the relationship between vitamin D status and cancer risk. The research analyzes observational studies regarding vitamin D levels and cancer, including colon, breast, prostate, and ovarian cancers. The majority of these studies suggest a protective effect of sufficient vitamin D status against cancer. The study proposes that improving vitamin D status, possibly through supplementation, could lower cancer incidence and mortality with minimal adverse effects and low cost.
For more in-depth study visit https://pubmed.ncbi.nlm.nih.gov/16380576/
Grant WB. A critical review of Vitamin D and Cancer: A report of the IARC Working Group. Dermato-endocrinology. 2009;1(1):25-33.
A critical review of Vitamin D and Cancer
William B. Grant’s critical review, “A Critical Review of Vitamin D and Cancer: A Report of the IARC Working Group,” published in Dermatoendocrinology in 2009, critiques the International Agency for Research on Cancer (IARC) report on vitamin D and cancer. Grant’s review highlights the IARC report’s acceptance of vitamin D’s role in preventing colorectal cancer but not breast cancer. He criticizes the IARC for dismissing certain studies and not fully recognizing the potential efficacy of vitamin D in cancer prevention. The review emphasizes the need for randomized controlled trials (RCTs) to conclusively determine vitamin D’s role in cancer prevention, although Grant also suggests that the current state of knowledge may be sufficient for public health policy decisions without waiting for RCT results.
For more in-depth study visit https://pubmed.ncbi.nlm.nih.gov/20046585/
Keum N, Giovannucci E. Vitamin D supplements and cancer incidence and mortality: a meta-analysis. British Journal of Cancer. 2014;111(5):976-980. doi:10.1038/bjc.2014.294.
Vitamin D supplements and cancer incidence and mortality
The article titled “Vitamin D Supplements and Cancer Incidence and Mortality: A Meta-Analysis” by Keum N and Giovannucci E, published in the British Journal of Cancer in 2014, conducted a meta-analysis to investigate the effects of vitamin D supplements on cancer incidence and mortality. The study found that over 2-7 years, vitamin D supplementation had little effect on total cancer incidence. The summary relative risk (RR) was close to 1.00, indicating no significant impact on cancer incidence.
For more in-depth study visit https://www.nature.com/articles/bjc2014294
Kennel KA, Drake MT. Vitamin D in the cancer patient. Current opinion in supportive and palliative care. 2013;7(3):272-277. doi:10.1097/SPC.0b013e3283640f74.
Vitamin D in the cancer patient.
The article titled “Vitamin D in the Cancer Patient” by Kurt A. Kennel and Matthew T. Drake, published in Current Opinion in Supportive and Palliative Care in 2013, likely discusses the role of vitamin D in cancer patients and its impact on supportive and palliative care.
For more in-depth study visit https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899831/
Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and Cancer: A review of molecular mechanisms. The Biochemical journal. 2012;441(1):61-76. doi:10.1042/BJ20110744.
Vitamin D and cancer: a review of molecular mechanisms
The article titled “Vitamin D and Cancer: A Review of Molecular Mechanisms” by Fleet JC, DeSmet M, Johnson R, Li Y, published in The Biochemical Journal in 2012, reviews the molecular mechanisms associated with the relationship between vitamin D and cancer.
For more in-depth study visit https://portlandpress.com/biochemj/article-abstract/441/1/61/47874
Vuolo L, Di Somma C, Faggiano A, Colao A. Vitamin D and Cancer. Frontiers in Endocrinology. 2012;3:58. doi:10.3389/fendo.2012.00058.
Vitamin D and Cancer
The primary focus of the study is to investigate the potential role of vitamin D in cancer prevention or management. The authors likely discuss the existing literature and research findings related to the impact of vitamin D on cancer risk, development, and progression. They may also delve into the mechanisms through which vitamin D might influence cancer cells or the immune system’s response to cancer.
For more in-depth study visit https://www.frontiersin.org/articles/10.3389/fendo.2012.00058/full?ref=healthdecider
Atoum M, Alzoughool F. Vitamin D and Breast Cancer: Latest Evidence and Future Steps. Breast Cancer : Basic and Clinical Research. 2017;11:1178223417749816. doi:10.1177/1178223417749816.
Vitamin D and breast cancer: latest evidence and future steps
The study titled “Vitamin D and Breast Cancer: Latest Evidence and Future Steps” by Atoum and Alzoughool was published in the journal “Breast Cancer: Basic and Clinical Research” in 2017. The authors aimed to review the latest evidence concerning the relationship between vitamin D and breast cancer.
In this study, Atoum and Alzoughool likely explored recent research findings related to vitamin D’s potential role in breast cancer risk, prevention, and treatment. They may have discussed the mechanisms through which vitamin D could impact breast cancer cells or the overall breast cancer landscape.
For more in-depth study visit https://journals.sagepub.com/doi/abs/10.1177/1178223417749816
Grant WB, Boucher BJ. Randomized controlled trials of vitamin D and cancer incidence: A modeling study. Slominski AT, ed. PLoS ONE. 2017;12(5):e0176448. doi:10.1371/journal.pone.0176448.
Randomized controlled trials of vitamin D and cancer incidence: a modeling study
The study titled “Randomized Controlled Trials of Vitamin D and Cancer Incidence: A Modeling Study” by Grant and Boucher was published in the journal “PLoS ONE” in 2017. The authors conducted a modeling study to assess the outcomes of randomized controlled trials (RCTs) examining the relationship between vitamin D supplementation and cancer incidence.
In this study, Grant and Boucher likely used mathematical models to analyze data from various RCTs that investigated whether vitamin D supplementation had an impact on the incidence of cancer. They aimed to provide insights into the potential effects of vitamin D supplementation on cancer prevention based on the combined evidence from these trials.
For more in-depth study visit https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176448
Available at https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/vitamin-d-fact-sheet.
Vitamin D Fact Sheet
The provided link appears to be the web address for the National Cancer Institute’s “Vitamin D Fact Sheet” page, which is available on the National Cancer Institute’s website. This fact sheet likely contains valuable information about vitamin D and its relationship with cancer, including details on the role of vitamin D in cancer prevention, sources of vitamin D, recommended dietary intake, and its potential impact on cancer risk.
For more in-depth study visit https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/vitamin-d-fact-sheet
Grant WB. A Review of the Evidence Supporting the Vitamin D-Cancer Prevention Hypothesis in 2017. Anticancer research. 2018; 38(2):1121-1136.
A Review of the Evidence Supporting the Vitamin D-Cancer Prevention Hypothesis in 2017
The study titled “A Review of the Evidence Supporting the Vitamin D-Cancer Prevention Hypothesis in 2017” by William B. Grant was published in the journal “Anticancer Research” in 2018. In this review article, Grant likely provides an overview of the existing evidence and research findings regarding the hypothesis that vitamin D may play a role in preventing cancer.
This review article likely summarizes and discusses the scientific literature up to 2017 related to the potential links between vitamin D and cancer prevention. It may cover epidemiological studies, clinical trials, and biological mechanisms through which vitamin D might affect cancer risk or progression.
For more in-depth study visit https://ar.iiarjournals.org/content/38/2/1121.short
Vaughan-Shaw PG, O’Sullivan F, Farrington SM, et al. The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. British journal of cancer. 2017; 1111111111111116(8):1092-1110.
The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis
The study titled “The Impact of Vitamin D Pathway Genetic Variation and Circulating 25-Hydroxyvitamin D on Cancer Outcome: Systematic Review and Meta-analysis” was published in the “British Journal of Cancer” in 2017. The authors of this study, including Vaughan-Shaw PG, O’Sullivan F, Farrington SM, and others, conducted a systematic review and meta-analysis to investigate the influence of genetic variations in the vitamin D pathway and circulating levels of 25-hydroxyvitamin D on cancer outcomes.
In this study, the authors likely examined a wide range of research articles, clinical studies, and genetic data to assess how variations in the vitamin D pathway and the levels of 25-hydroxyvitamin D might impact cancer prognosis, progression, or treatment outcomes across different cancer types.
For more in-depth study visit https://www.nature.com/articles/bjc201744
Shekarriz-Foumani R, Khodaie F. The Correlation of Plasma 25-Hydroxyvitamin D Deficiency With Risk of Breast Neoplasms: A Systematic Review. Iranian journal of cancer prevention. 2016; 9(3):e4469
The correlation of plasma 25-hydroxyvitamin D deficiency with risk of breast neoplasms: a systematic review
The study titled “The Correlation of Plasma 25-Hydroxyvitamin D Deficiency With Risk of Breast Neoplasms: A Systematic Review” by Shekarriz-Foumani and Khodaie was published in the “Iranian Journal of Cancer Prevention” in 2016. In this systematic review, the authors likely examined existing research to investigate the correlation between plasma 25-hydroxyvitamin D deficiency and the risk of developing breast neoplasms (breast cancer).
The study probably involved a thorough analysis of scientific literature, clinical studies, and relevant data to assess the relationship between low levels of 25-hydroxyvitamin D in the blood and the likelihood of developing breast cancer.
For more in-depth study visit https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038833/
Dimitrakopoulou VI, Tsilidis KK, Haycock PC, et al. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study. BMJ (Clinical research ed.). 2017; 359:j4761.
Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study
The study titled “Circulating Vitamin D Concentration and Risk of Seven Cancers: Mendelian Randomisation Study” by Dimitrakopoulou et al. was published in BMJ (British Medical Journal) in 2017. This study used Mendelian randomization, a genetic epidemiology approach, to investigate the association between circulating vitamin D concentration and the risk of seven different types of cancers.
The authors likely examined genetic data from large populations to assess whether variations in genes related to vitamin D metabolism are associated with cancer risk. By using this Mendelian randomization approach, they aimed to determine whether there is a causal relationship between vitamin D levels and the risk of developing these specific cancers.
For more in-depth study visit https://www.bmj.com/content/359/bmj.j4761.long
McDonnell SL, Baggerly C, French CB, et al. Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study. PloS one. 2016; 11(4):e0152441.
Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study
The study titled “Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study” by McDonnell et al. was published in the journal “PLoS ONE” in 2016. In this study, the authors conducted a pooled analysis of data from randomized trials and prospective cohort studies to investigate the association between serum 25-hydroxyvitamin D concentrations (a form of vitamin D) and the risk of developing cancer.
The study likely aimed to assess whether individuals with higher levels of vitamin D in their blood (specifically, concentrations of 40 ng/ml or higher) had a significantly reduced risk of developing cancer, compared to those with lower vitamin D levels.
For more in-depth study visit https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152441
Lappe J, Watson P, Travers-Gustafson D, et al. Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial. JAMA. 2017; 317(12):1234-1243.
Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial
The study titled “Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial” by Lappe et al. was published in JAMA (Journal of the American Medical Association) in 2017. In this randomized clinical trial, the authors investigated the impact of vitamin D and calcium supplementation on the incidence of cancer in older women.
The study likely involved the random allocation of participants into different groups, with some receiving vitamin D and calcium supplements and others receiving a placebo. The researchers then followed these women over a period to assess whether the supplementation had any effect on their risk of developing cancer.
For more in-depth study visit https://jamanetwork.com/journals/jama/article-abstract/2613159
Braillon A. Vitamin D and Breast Cancer Survival: The Good and the Bad. JAMA oncology. 2017; 3(8):1138-1139.
Vitamin D and Breast Cancer Survival: The Good and the Bad
The article titled “Vitamin D and Breast Cancer Survival: The Good and the Bad” by Braillon was published in JAMA Oncology in 2017. In this commentary or editorial piece, Braillon likely discusses the complex relationship between vitamin D levels and breast cancer survival.
This article may provide insights into both the positive and negative aspects of vitamin D in relation to breast cancer outcomes. It could discuss the potential benefits of adequate vitamin D levels in improving breast cancer survival, as well as any challenges or limitations associated with vitamin D supplementation or its effects on breast cancer prognosis.
For more in-depth study visit https://jamanetwork.com/journals/jamaoncology/article-abstract/2631193
Baumann M, Dani SU, Dietrich D, et al. Vitamin D levels in Swiss breast cancer survivors. Swiss medical weekly. 2018; 148:w14576.
Vitamin D levels in Swiss breast cancer survivors.
The study titled “Vitamin D Levels in Swiss Breast Cancer Survivors” by Baumann et al. was published in the “Swiss Medical Weekly” in 2018. In this study, the authors likely investigated the vitamin D levels in breast cancer survivors in Switzerland.
The research may have involved measuring the serum or blood levels of vitamin D in a group of Swiss women who had previously been diagnosed with breast cancer and were now considered survivors. The study may have explored whether there was any correlation between vitamin D levels and the breast cancer survivors’ health or prognosis.
For more in-depth study visit https://smw.ch/index.php/smw/article/view/2436
Chlebowski RT. Vitamin D and breast cancer: interpreting current evidence. Breast Cancer Research : BCR. 2011;13(4):217. doi:10.1186/bcr2846.
Vitamin D and breast cancer: interpreting current evidence
The article titled “Vitamin D and Breast Cancer: Interpreting Current Evidence” by Chlebowski RT was published in “Breast Cancer Research” (BCR) in 2011. In this article, Chlebowski likely discusses and interprets the existing evidence regarding the relationship between vitamin D and breast cancer.
Chlebowski’s article may provide insights into the current state of knowledge on the topic, including findings from research studies and clinical trials related to the potential role of vitamin D in breast cancer prevention, development, or management. The article may also address the challenges and implications of interpreting the available evidence.
For more in-depth study visit https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr2846
Lu D, Jing L, Zhang S. Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis. Medicine. 2016; 95(18):e3535.
Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis
The study titled “Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis” by Lu, Jing, and Zhang was published in the journal “Medicine” in 2016. In this meta-analysis, the authors likely conducted a systematic review of existing research studies and pooled the data to assess the association between vitamin D receptor polymorphism (genetic variations in the vitamin D receptor gene) and the risk of developing breast cancer.
The study may have included data from various research articles and investigated whether specific genetic variations in the vitamin D receptor gene are associated with an increased or decreased risk of breast cancer.
For more in-depth study visit https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863774/
de Sousa Almeida-Filho B, De Luca Vespoli H, Pessoa EC, Machado M, Nahas-Neto J, Nahas EAP. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women. The Journal of steroid biochemistry and molecular biology. 2017; 174:284-289.
Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women
The study titled “Vitamin D Deficiency is Associated with Poor Breast Cancer Prognostic Features in Postmenopausal Women” by de Sousa Almeida-Filho et al. was published in “The Journal of Steroid Biochemistry and Molecular Biology” in 2017. In this study, the authors likely investigated the relationship between vitamin D deficiency and specific prognostic features of breast cancer in postmenopausal women.
The research may have involved examining clinical and pathological data from postmenopausal women diagnosed with breast cancer and assessing whether low vitamin D levels were associated with more adverse prognostic factors or characteristics of the disease.
For more in-depth study visit https://www.sciencedirect.com/science/article/pii/S0960076017302789
Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and Immune Function. Nutrients. 2013;5(7):2502-2521. doi:10.3390/nu5072502.
Vitamin D and Immune Function
The study titled “Vitamin D and Immune Function” by Prietl, Treiber, Pieber, and Amrein was published in the journal “Nutrients” in 2013. In this study, the authors likely explored the relationship between vitamin D and immune function.
The research may have covered various aspects of how vitamin D influences the immune system, including its role in immune response modulation, the impact of vitamin D deficiency on immune function, and potential therapeutic implications for immune-related conditions.
For more in-depth study visit https://www.mdpi.com/2072-6643/5/7/2502
Hewison M. Vitamin D and immune function: an overview. The Proceedings of the Nutrition Society. 2012; 71(1):50-61.
Vitamin D and immune function: an overview
The article titled “Vitamin D and Immune Function: An Overview” by Hewison was published in “The Proceedings of the Nutrition Society” in 2012. In this overview article, Hewison likely provides a comprehensive summary and discussion of the relationship between vitamin D and immune function.
The article may cover various aspects of how vitamin D influences the immune system, including its role in immune response regulation, the impact of vitamin D deficiency on immune function, and potential therapeutic implications for immune-related conditions
For more in-depth study visit https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/vitamin-d-and-immune-function-an-overview/302152110AEE222430F44164E53FEA90
Aranow C. Vitamin D and the immune system. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2011; 59(6):881-6.
Vitamin D and the immune system.
The article titled “Vitamin D and the Immune System” by Aranow was published in the “Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research” in 2011. In this article, Aranow likely explores the relationship between vitamin D and the immune system.
The article may discuss the role of vitamin D in modulating immune function, including its effects on immune cell regulation, inflammation, and the body’s defense mechanisms. It might also address the potential impact of vitamin D deficiency on immune-related health conditions.
For more in-depth study visit https://journals.sagepub.com/doi/abs/10.2310/JIM.0b013e31821b8755
Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Frontiers in Physiology. 2014;5:151. doi:10.3389/fphys.2014.00151.
Impact of vitamin D on immune function: lessons learned from genome-wide analysis
The study titled “Impact of Vitamin D on Immune Function: Lessons Learned from Genome-wide Analysis” by Chun, Liu, Modlin, Adams, and Hewison was published in the journal “Frontiers in Physiology” in 2014. In this study, the authors likely discuss the influence of vitamin D on immune function by drawing insights from genome-wide analysis.
The research may have involved examining the genomic effects of vitamin D on the immune system, exploring how vitamin D regulates immune-related genes and pathways, and providing valuable lessons from these analyses.
For more in-depth study visit https://www.frontiersin.org/articles/10.3389/fphys.2014.00151/full
Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. The American journal of clinical nutrition. 2004; 80(6 Suppl):1717S-20S.
Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system
The article titled “Vitamin D Status, 1,25-Dihydroxyvitamin D3, and the Immune System” by Cantorna, Zhu, Froicu, and Wittke was published in “The American Journal of Clinical Nutrition” in 2004. In this article, the authors likely discuss the relationship between vitamin D status, specifically 1,25-dihydroxyvitamin D3 (the active form of vitamin D), and the immune system.
The article may delve into the role of vitamin D in immune system regulation, its effects on immune cell function, and how vitamin D status can impact immune responses.
For more in-depth study visit https://academic.oup.com/ajcn/article-abstract/80/6/1717S/4690517
Pandolfi F, Franza L, Mandolini C, Conti P. Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. Clinical therapeutics. 2017; 39(5):884-893.
Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer
The article titled “Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer” by Pandolfi, Franza, Mandolini, and Conti was published in “Clinical Therapeutics” in 2017. In this article, the authors likely discuss the immune-modulating effects of vitamin D, with a particular focus on its potential role in preventing and treating cancer.
The article may provide insights into how vitamin D can impact the immune system and its relevance in cancer prevention and therapeutic strategies. It might cover topics such as the mechanisms through which vitamin D affects immune responses and its potential implications in cancer management.
For more in-depth study visit https://www.sciencedirect.com/science/article/pii/S0149291817301947
Aranow C. Vitamin D and the Immune System. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2011;59(6):881-886. doi:10.231/JIM.0b013e31821b8755.
Vitamin D and the Immune System
The article titled “Vitamin D and the Immune System” by Aranow was published in the “Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research” in 2011. In this article, Aranow likely explores the relationship between vitamin D and the immune system.
The article may discuss the role of vitamin D in modulating immune function, including its effects on immune cell regulation, inflammation, and the body’s defense mechanisms. It might also address the potential impact of vitamin D deficiency on immune-related health conditions.
For more in-depth study visit https://journals.sagepub.com/doi/abs/10.2310/JIM.0b013e31821b8755
Djukic M, Onken ML, Schütze S, et al. Vitamin d deficiency reduces the immune response, phagocytosis rate, and intracellular killing rate of microglial cells. Infection and immunity. 2014; 82(6):2585-94.
Vitamin D deficiency reduces the immune response, phagocytosis rate, and intracellular killing rate of microglial cells
The study titled “Vitamin D Deficiency Reduces the Immune Response, Phagocytosis Rate, and Intracellular Killing Rate of Microglial Cells” by Djukic, Onken, Schütze, and others was published in “Infection and Immunity” in 2014. In this study, the authors likely investigated the effects of vitamin D deficiency on the immune response and specific functions of microglial cells.
Microglial cells are a type of immune cell in the central nervous system, and the study may have explored how vitamin D deficiency impacts their immune functions, including their ability to respond to infections, phagocytosis (engulfing and digesting pathogens), and intracellular killing of microorganisms
For more in-depth study visit https://journals.asm.org/doi/abs/10.1128/IAI.01814-14
Adamczak DM. The Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases-A Review. International journal of molecular sciences. 2017; 18(11)
The Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases-A Review
The article titled “The Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases-A Review” by Adamczak DM was published in the “International Journal of Molecular Sciences” in 2017. In this review article, the author likely discusses the involvement of Toll-like receptors (TLRs) and vitamin D in the context of cardiovascular diseases.
The review may cover topics such as the role of TLRs in inflammation and immune responses related to cardiovascular conditions, as well as the potential influence of vitamin D on these processes. It might explore how these factors interact and their implications for cardiovascular health.
For more in-depth study visit https://www.mdpi.com/1422-0067/18/11/2252
Endocrine Society. “Vitamin D deficiency may compromise immune function.” ScienceDaily. ScienceDaily, 25 February 2014.<www.sciencedaily.com/releases/2014/02/140225134233.htm>.
Vitamin D deficiency may compromise immune function
The provided citation refers to a ScienceDaily article published on February 25, 2014, titled “Vitamin D deficiency may compromise immune function.” This article likely reports on research or findings related to the potential impact of vitamin D deficiency on immune function.
The article may discuss how inadequate levels of vitamin D could potentially affect the immune system, making it less effective in responding to infections and diseases. It may highlight the importance of maintaining sufficient vitamin D levels for overall health, including immune health.
Soni M, Kos K, Lang IA, Jones K, Melzer D, Llewellyn DJ. Vitamin D and cognitive function. Scandinavian journal of clinical and laboratory investigation. Supplementum. 2012; 243:79-82
Vitamin D and Cognitive Function
The study titled “Vitamin D and Cognitive Function” by Soni, Kos, Lang, Jones, Melzer, and Llewellyn was published in the “Scandinavian Journal of Clinical and Laboratory Investigation – Supplementum” in 2012. In this study, the authors likely explored the relationship between vitamin D and cognitive function.
The research may have investigated the potential impact of vitamin D levels on cognitive abilities and brain health. It may have included assessments of cognitive function in individuals with varying vitamin D status.
For more in-depth study visit https://www.tandfonline.com/doi/abs/10.3109/00365513.2012.681969
Maddock J, Zhou A, Cavadino A, et al. Vitamin D and cognitive function: A Mendelian randomisation study. Scientific Reports. 2017;7:13230. doi:10.1038/s41598-017-13189-3.
Vitamin D and cognitive function: A Mendelian randomisation study
The study titled “Vitamin D and Cognitive Function: A Mendelian Randomisation Study” by Maddock, Zhou, Cavadino, and others was published in “Scientific Reports” in 2017. In this study, the authors likely conducted a Mendelian randomization analysis to investigate the potential causal relationship between vitamin D and cognitive function.
Mendelian randomization is a genetic epidemiology approach that uses genetic variants as instrumental variables to assess causality in observational studies. The study may have leveraged genetic data to examine whether variations in genes related to vitamin D metabolism are associated with cognitive function.
For more in-depth study visit https://katalog.ub.uni-heidelberg.de/titel/68187621
Anastasiou CA, Yannakoulia M, Scarmeas N. Vitamin D and cognition: an update of the current evidence. Journal of Alzheimer’s disease : JAD. 2014; 42 Suppl 3:S71-80.
Vitamin D and Cognition: An Update of the Current Evidence
The article titled “Vitamin D and Cognition: An Update of the Current Evidence” by Anastasiou, Yannakoulia, and Scarmeas was published in the “Journal of Alzheimer’s Disease” (JAD) in 2014 as a supplement (42 Suppl 3), specifically in pages S71-80. In this article, the authors likely provide an updated review of the existing evidence regarding the relationship between vitamin D and cognitive function.
The article may cover recent research findings and studies related to how vitamin D levels are associated with cognitive abilities, including the potential role of vitamin D in cognitive decline and disorders like Alzheimer’s disease.
For more in-depth study visit https://content.iospress.com/articles/journal-of-alzheimers-disease/jad132636
Miller JW, Harvey DJ, Beckett LA, et al. Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. JAMA neurology. 2015; 72(11):1295-303.
Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults
The study titled “Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults” by Miller, Harvey, Beckett, and others was published in “JAMA Neurology” in 2015. In this study, the authors likely investigated the relationship between vitamin D status and the rate of cognitive decline in a diverse group of older adults.
The research may have involved measuring vitamin D levels in study participants and tracking their cognitive function over time. The study likely aimed to determine whether there is an association between vitamin D status and the rate of cognitive decline in older individuals.
For more in-depth study visit https://jamanetwork.com/journals/jamaneurology/article-abstract/2436596
Kent ST, Kabagambe EK, Wadley VG, Howard VJ, Crosson WL, Al-Hamdan MZ, Judd SE, Peace F, McClure LA. The relationship between long-term sunlight radiation and cognitive decline in the REGARDS cohort study. Int J Biometeorol. 2014 Apr;58(3):361-70.
The relationship between long-term sunlight radiation and cognitive decline in the REGARDS cohort study
The study titled “The Relationship Between Long-term Sunlight Radiation and Cognitive Decline in the REGARDS Cohort Study” by Kent, Kabagambe, Wadley, Howard, Crosson, Al-Hamdan, Judd, Peace, and McClure was published in the “International Journal of Biometeorology” in April 2014. In this study, the authors likely examined the association between long-term exposure to sunlight radiation and cognitive decline in participants from the REGARDS cohort study.
The research may have involved assessing the sunlight exposure levels experienced by participants over an extended period and exploring whether there is a relationship between such exposure and cognitive function or cognitive decline.
For more in-depth study visit https://link.springer.com/article/10.1007/s00484-013-0631-5
Goodwill AM, Szoeke C. A Systematic Review and Meta-Analysis of The Effect of Low Vitamin D on Cognition. Journal of the American Geriatrics Society, 2017
A Systematic Review and Meta-Analysis of The Effect of Low Vitamin D on Cognition
The systematic review and meta-analysis by Goodwill and Szoeke (2017) investigated the impact of low vitamin D levels on cognition. The study revealed a comprehensive understanding of the association between vitamin D deficiency and cognitive function.
For more details visit https://agsjournals.onlinelibrary.wiley.com/doi/abs/10.1111/jgs.15012
Feart, C. et al. Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer’s disease in older adults. Alzheimer’s & Dementia, 2017
Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer’s disease in older adults
The study titled “Associations of Lower Vitamin D Concentrations with Cognitive Decline and Long-Term Risk of Dementia and Alzheimer’s Disease in Older Adults” by Feart et al. was published in “Alzheimer’s & Dementia” in 2017. In this study, the authors likely investigated the associations between lower vitamin D concentrations and cognitive decline, as well as the long-term risk of dementia and Alzheimer’s disease in older adults.
The research may have involved examining vitamin D levels in older individuals and tracking their cognitive function over time. Additionally, the study may have explored whether low vitamin D concentrations were associated with an increased risk of developing dementia or Alzheimer’s disease.
For more details visit https://www.sciencedirect.com/science/article/pii/S1552526017301383
Matchar DB, Chei CL, Yin ZX, Koh V, Chakraborty B, Shi XM, Zeng Y. Vitamin D Levels and the Risk of Cognitive Decline in Chinese Elderly People: the Chinese Longitudinal Healthy Longevity Survey. The Gerontological Society of America, 2016
Moon J., et al. Serum 25-hydroxyvitamin D level and the risk of mild cognitive impairment and dementia: the Korean Longitudinal Study on Health and Aging (KLoSHA). Clinical Endocrinology, 2015
Serum 25-Hydroxyvitamin D Level and the Risk of Mild Cognitive Impairment and Dementia: The Korean Longitudinal Study on Health and Aging (KLoSHA)
The study titled “Serum 25-Hydroxyvitamin D Level and the Risk of Mild Cognitive Impairment and Dementia: The Korean Longitudinal Study on Health and Aging (KLoSHA)” by Moon et al. was published in “Clinical Endocrinology” in 2015. In this study, the authors likely investigated the relationship between serum 25-hydroxyvitamin D levels and the risk of developing mild cognitive impairment (MCI) and dementia in participants from the Korean Longitudinal Study on Health and Aging (KLoSHA).
The research may have involved measuring vitamin D levels in study participants and longitudinally tracking their cognitive health to assess whether there is an association between lower vitamin D levels and an increased risk of MCI and dementia.
For more details visit https://onlinelibrary.wiley.com/doi/abs/10.1111/cen.12733
Karakis, I. et al. Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study. Journal of Alzheimer’s Disease, 2015.
Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study
The study titled “Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study” by Karakis et al. was published in the “Journal of Alzheimer’s Disease” in 2015. In this study, the authors likely investigated the association between serum vitamin D levels and the risk of developing dementia, as well as subclinical indicators of brain aging, among participants from the Framingham Heart Study.
The research may have included measuring vitamin D levels in study participants and assessing their cognitive function and brain health over time to determine whether lower serum vitamin D is linked to an increased risk of dementia or subclinical signs of brain aging.
For more details visit https://content.iospress.com/articles/journal-of-alzheimers-disease/jad150991
Pettersen, J. et al. The Effects of Vitamin D Insufficiency and Seasonal Decrease on Cognition. The Canadian Journal of Neurological Sciences, 2014
The effects of Vitamin D Insufficiency and Seasonal Decrease on cognition
The study “The Effects of Vitamin D Insufficiency and Seasonal Decrease on Cognition” published in The Canadian Journal of Neurological Sciences discusses the relationship between Vitamin D3 insufficiency and cognitive function, particularly in relation to seasonal changes. The findings suggest that insufficient levels of Vitamin D3, especially with significant seasonal declines, are associated with poorer performance in working memory and executive functioning. The study highlights the potential need for maintaining sufficient Vitamin D3 levels throughout the year, possibly requiring supplementation during winter in higher latitudes.
For more details visit https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/effects-of-vitamin-d-insufficiency-and-seasonal-decrease-on-cognition/7B80C9B42E47B7B8AC1B57DB450DACB6
Balion C, Griffith LE, Stifler L, et al. Vitamin D, cognition, and dementia: A systematic review and meta-analysis. Neurology. September 25, 2012
A systematic review and meta-analysis
The study titled “Vitamin D, cognition, and dementia: A systematic review and meta-analysis” by Balion C, Griffith LE, Stifler L, and others, published on September 25, 2012, in Neurology, suggests that lower concentrations of vitamin D are associated with poorer cognitive function and a higher risk of Alzheimer’s disease (AD). However, the authors emphasize the need for further research to fully understand the significance and potential public health benefits of this association. This conclusion is based on a systematic review and analysis of existing studies on the topic.
For more details visit https://pubmed.ncbi.nlm.nih.gov/23008220/
Miller JW, Harvey DJ, Beckett LA, Green R, Farias ST, Reed BR, Olichney JM, Mungas DM, DeCarli C. Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. JAMA Neurol. 2015
Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults
The study “Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults,” published in JAMA Neurology in 2015 by Miller JW, Harvey DJ, Beckett LA, and colleagues, found a significant association between low Vitamin D (VitD) status and accelerated cognitive decline in diverse older adults, including African American and Hispanic individuals. The study involved 382 participants from an outpatient clinic who were enrolled between February 2002 and August 2010. The participants underwent baseline assessment and yearly follow-up visits, during which their serum 25-hydroxyvitamin D (25-OHD) levels were measured.
For more details visit https://pubmed.ncbi.nlm.nih.gov/26366714/
Bjorn, G. et al. Linking vitamin D status, executive functioning and self-perceived mental health in adolescents through multivariate analysis: A randomized double-blind placebo control trial. Scandinavian Journal of Psychology, 2017
Linking vitamin D status, executive functioning and self-perceived mental health in adolescents through multivariate analysis: A randomized double-blind placebo control trial
The study “Linking vitamin D status, executive functioning and self-perceived mental health in adolescents through multivariate analysis: A randomized double-blind placebo control trial” by Bjørn Grung and colleagues, published in the Scandinavian Journal of Psychology in 2017, aimed to investigate the effects of vitamin D supplementation on vitamin D status, executive functioning, and self-perceived mental health in Norwegian adolescents during winter.
For more details visit https://pubmed.ncbi.nlm.nih.gov/28252190/
Pettersen, J. Does high dose vitamin D supplementation enhance cognition?: A randomized trial in healthy adults. Experimental Gerontology, 2017.
Does high dose vitamin D supplementation enhance cognition?: A randomized trial in healthy adults
The study “Does high dose vitamin D supplementation enhance cognition?: A randomized trial in healthy adults,” conducted by Pettersen J. and published in Experimental Gerontology in 2017, explored the impact of high-dose vitamin D supplementation on cognitive performance. The study involved 82 healthy adults from northern British Columbia, Canada, who were divided into two groups: a high-dose group receiving 4000 IU/day of vitamin D3 and a low-dose group receiving 400 IU/day. The trial lasted 18 weeks, and cognitive performance was assessed through various tests.
For more details visit https://www.sciencedirect.com/science/article/pii/S0531556516303230
G Hajiluian, G Nameni, P Shahabi, M Mesgari-Abbasi, S Sadigh-Eteghad, M A Farhangi, Vitamin D administration, cognitive function, BBB permeability and neuro-inflammatory factors in high-fat diet induced obese rats, International Journal of Obesity, 2017
Vitamin D administration, cognitive function, BBB permeability and neuro-inflammatory factors in high-fat diet induced obese rats
The study by Hajiluian et al., published in the International Journal of Obesity in 2017, examined the effects of vitamin D administration on various factors including cognitive function, brain-derived neurotrophic factor (BDNF) levels in the hippocampus, and blood-brain barrier (BBB) permeability in obese rats induced by a high-fat diet.
In the study, male Wistar rats were divided into groups and fed either a control diet or a high-fat diet for 16 weeks. Following this period, the groups were further subdivided, and some received vitamin D supplementation for 5 weeks. The researchers used the Morris water maze test to assess cognitive function and measured BDNF and NF-κB concentrations in the hippocampus, along with serum vitamin D levels.
For more details visit https://pubmed.ncbi.nlm.nih.gov/28093570/
Sakiko Abe, Osamu Ezaki, and Motohisa Suzuki. Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Benefit Cognition in Frail Elderly Adults: A Randomized Controlled Trial. 133 J Nutr Sci Vitaminol, 2017
Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Benefit Cognition in Frail Elderly Adults: A Randomized Controlled Trial
The study by Sakiko Abe, Osamu Ezaki, and Motohisa Suzuki, titled “Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Benefit Cognition in Frail Elderly Adults: A Randomized Controlled Trial,” published in the Journal of Nutritional Science and Vitaminology in 2017, explored the impact of combined supplementation on cognitive function in frail elderly individuals.
In this study, 38 elderly nursing home residents were enrolled in a 3-month randomized, controlled, parallel group trial. The participants were divided into three groups: one receiving a supplement enriched with L-leucine (1.2 g) and cholecalciferol (vitamin D3, 20 μg) combined with 6 g of medium-chain triglycerides (MCTs), another receiving the same supplement with 6 g of long-chain triglycerides (LCTs), and a control group that did not receive any supplements.
For more details visit https://www.jstage.jst.go.jp/article/jnsv/63/2/63_133/_article
Pettersen JA. Vitamin D and executive functioning: Are higher levels better? J Clin Exp Neuropsychol. 2015 Dec 27:1-11.
Vitamin D and executive functioning: Are higher levels better
In the study “Vitamin D and executive functioning: Are higher levels better?” by Jacqueline A. Pettersen, published in the Journal of Clinical and Experimental Neuropsychology in 2016, the research focused on whether high levels of vitamin D, beyond the standard sufficiency threshold, are linked to better executive functioning. The study involved healthy adults who were assessed on various cognitive tasks. The findings suggested that individuals with vitamin D levels exceeding 100 nmol/L displayed significantly better performance in verbal fluency compared to those with lower levels. This research indicates that higher than typically sufficient levels of vitamin D may be beneficial for certain aspects of executive functioning, particularly verbal fluency.
For more details visit https://pubmed.ncbi.nlm.nih.gov/26708262/
Miller Bj, Whisner Cm, Johnston Cs. Vitamin D Supplementation Appears To Increase Plasma Aβ40 In Vitamin D Insufficient Older Adults: A Pilot Randomized Controlled Trial. J Alzheimers Dis. 2016 Mar 31.
Vitamin D Supplementation Appears To Increase Plasma Aβ40 In Vitamin D Insufficient Older Adults: A Pilot Randomized Controlled Trial
The study titled “Vitamin D Supplementation Appears to Increase Plasma Aβ40 in Vitamin D Insufficient Older Adults: A Pilot Randomized Controlled Trial” by Miller BJ, Whisner CM, and Johnston CS, published in the Journal of Alzheimer’s Disease on March 31, 2016, focuses on the relationship between Vitamin D supplementation and the levels of plasma amyloid-β (Aβ40) in older adults. The study is particularly significant because low levels of plasma amyloid-β are linked to Alzheimer’s disease.
The trial lasted for 8 weeks and involved adults who were insufficient in Vitamin D. These participants were randomly assigned to either a placebo group or a Vitamin D supplement group. The supplement group received 50,000 IU of Vitamin D per week. The study found that the group receiving Vitamin D supplements showed a greater increase in plasma Aβ40 levels compared to the control group. The increase was particularly notable in participants who were 60 years or older.
The significance of this finding lies in the potential implication that Vitamin D may help in increasing plasma Aβ levels, which in turn could suggest a decrease in brain amyloid-β. This is an important area of research given the ongoing efforts to understand and combat Alzheimer’s disease.
For the full article visit https://pubmed.ncbi.nlm.nih.gov/27031473/
Latimer, C. et al. Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rat. Proceedings of the National Academy of Sciences of the United States of America, 2014.
Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rat
The study by Latimer et al., published in 2014 in the Proceedings of the National Academy of Sciences, investigated the effects of Vitamin D on cognitive decline and hippocampal function in aging rats. The research involved treating middle-aged rats (11-13 months old) with different dietary levels of Vitamin D3 (cholecalciferol) for six months. The outcomes measured included learning, memory behavior, and changes in synaptic proteins in hippocampal neurons. The study found that high dietary Vitamin D3 improved performance in cognitive tasks and increased the excitability of hippocampal neurons, suggesting that Vitamin D may have a beneficial role in preserving cognitive function during aging
For the full article visit https://pubmed.ncbi.nlm.nih.gov/25267625/
Durk, M. et al. 1α,25-Dihydroxyvitamin D3 Reduces Cerebral Amyloid-β Accumulation and Improves Cognition in Mouse Models of Alzheimer’s Disease. The Journal of Neuroscience, 2014.
1α, 25-Dihydroxyvitamin D3 reduces cerebral amyloid-β accumulation and improves cognition in mouse models of Alzheimer’s disease
The study by Durk et al., published in The Journal of Neuroscience in 2014, explored the role of the vitamin D receptor (VDR) in reducing cerebral amyloid-β accumulation in mouse models of Alzheimer’s disease. The study found that short-term treatment with 1α,25-dihydroxyvitamin D3, the active ligand of VDR, resulted in higher brain P-glycoprotein levels and lower soluble amyloid-β levels. Long-term treatment led to a reduction in soluble and insoluble plaque-associated amyloid-β, especially in the hippocampus, and improved conditioned fear memory. This suggests the potential of VDR as a therapeutic target in Alzheimer’s disease prevention and treatment.
For the full article visit https://pubmed.ncbi.nlm.nih.gov/24849345/
Available at https://www.medscape.com/viewarticle/850943.
Low Vitamin D Linked to Cognitive Decline
The study explores a novel approach to measure blood pressure by analyzing the wideband external pulse signal. While the exact details of the study are not provided in the search result, the link directs to the Medscape website where the full article can be accessed for a comprehensive understanding of the research.
For more information https://www.medscape.com/viewarticle/850943
Balion C, Griffith LE, Strifler L, et al. Vitamin D, cognition, and dementia: A systematic review and meta-analysis. Neurology. 2012;79(13):1397-1405. doi:10.1212/WNL.0b013e31826c197f.
Vitamin D, cognition, and dementia: A systematic review and meta-analysis
The study “Vitamin D, cognition, and dementia: A systematic review and meta-analysis” by Balion et al., published in Neurology in 2012, systematically reviews and meta-analyzes the relationship between vitamin D levels and cognitive function and dementia. The focus is on assessing whether low vitamin D levels are associated with poorer cognitive performance or a higher risk of developing dementia. This study is significant in the field of neurology as it seeks to clarify the potential role of vitamin D in cognitive health and the prevention of cognitive decline and dementia. For more detailed insights, you can refer to the full article on Neurology’s website.
For the full article visit https://n.neurology.org/content/79/13/1397.short
Kuźma E, Soni M, Littlejohns TJ, et al. Vitamin D and memory decline: Two population-based prospective studies. Journal of Alzheimer’s disease : JAD. 2016;50(4):1099-1108. doi:10.3233/JAD-150811
Vitamin D and memory decline: two population-based prospective studies
The study “Vitamin D and memory decline: Two population-based prospective studies” by Kuźma et al., published in the Journal of Alzheimer’s Disease in 2016, investigates the association between vitamin D levels and the rate of memory decline. The research was conducted using data from two large, population-based studies, providing a comprehensive analysis of how vitamin D might influence memory over time. This study is particularly relevant for understanding the potential impact of vitamin D on cognitive health and the progression of memory-related issues in aging populations. For a detailed understanding of the study’s findings and methodology, you can refer to the article in the Journal of Alzheimer’s Disease.
For the full article visit https://content.iospress.com/articles/journal-of-alzheimers-disease/jad150811
Annweiler C, Dursun E, Féron F, et al. ‘Vitamin D and cognition in older adults’: updated international recommendations. Journal of internal medicine. 2015; 277(1):45-57
Vitamin D and cognition in older adults’: updated international recommendations
The article “Vitamin D and cognition in older adults’: updated international recommendations” by Annweiler et al., published in the Journal of Internal Medicine in 2015, provides updated guidelines on the role of vitamin D in cognitive health for older adults. It synthesizes current research to offer insights into how vitamin D might influence cognitive function in the elderly and suggests recommendations for vitamin D intake and management. This work is particularly significant for clinicians and researchers focusing on the intersection of nutrition, aging, and cognitive health. For a comprehensive understanding, you can refer to the article in the Journal of Internal Medicine.
For the full article visit https://onlinelibrary.wiley.com/doi/abs/10.1111/joim.12279
Liu GL, Pi HC, Hao L, Li DD, Wu YG, Dong J. Vitamin D Status Is an Independent Risk Factor for Global Cognitive Impairment in Peritoneal Dialysis Patients. PloS one. 2015; 10(12):e0143782
Vitamin D Status Is an Independent Risk Factor for Global Cognitive Impairment in Peritoneal Dialysis Patients
The study “Vitamin D Status Is an Independent Risk Factor for Global Cognitive Impairment in Peritoneal Dialysis Patients” by Liu GL et al., published in PloS One in 2015, examines the relationship between vitamin D levels and cognitive impairment in patients undergoing peritoneal dialysis. This research is significant as it explores the potential impact of vitamin D status on cognitive health in a specific patient population, providing insights that may be valuable for clinical management and treatment strategies. The full article in PloS One offers detailed information on their findings and methodology.
For the full article visit https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0143782
Di Somma C, Scarano E, Barrea L, et al. Vitamin D and Neurological Diseases: An Endocrine View. International journal of molecular sciences. 2017; 18(11).
Vitamin D and neurological diseases: an endocrine view
The article “Vitamin D and Neurological Diseases: An Endocrine View” by Di Somma et al., published in the International Journal of Molecular Sciences in 2017, discusses the role of Vitamin D in neurological diseases from an endocrine perspective. It explores the potential mechanisms through which Vitamin D might influence neurological health and examines its implications in various neurological disorders. This article is particularly relevant for understanding the complex interactions between endocrine factors and neurological health. For detailed information, you can access the full article in the International Journal of Molecular Sciences.
For the full article visit https://www.mdpi.com/1422-0067/18/11/2482
Lerner PP, Sharony L, Miodownik C. Association between mental disorders, cognitive disturbances and vitamin D serum level: Current state. Clinical nutrition ESPEN. 2018; 23:89-102.
Association between mental disorders, cognitive disturbances and vitamin D serum level: Current state
The article “Association between mental disorders, cognitive disturbances and vitamin D serum level: Current state” by Lerner PP, Sharony L, and Miodownik, published in Clinical Nutrition ESPEN in 2018, reviews the existing research on the relationship between vitamin D levels and various mental disorders and cognitive disturbances. It provides an overview of current understanding in this field and discusses the potential implications of vitamin D status on mental health. For a comprehensive review of the findings, you can refer to the article in Clinical Nutrition ESPEN.
For the full article visit https://www.sciencedirect.com/science/article/pii/S2405457716303515
Kimball SM, Mirhosseini N, Rucklidge J. Database Analysis of Depression and Anxiety in a Community Sample-Response to a Micronutrient Intervention. Nutrients. 2018; 10(2).
Database Analysis of Depression and Anxiety in a Community Sample-Response to a Micronutrient Intervention
The study “Database Analysis of Depression and Anxiety in a Community Sample-Response to a Micronutrient Intervention” by Kimball SM, Mirhosseini N, and Rucklidge, published in Nutrients in 2018, investigates the effects of micronutrient supplementation on depression and anxiety. It analyzes data from a community sample to understand the impact of nutritional intervention on mental health conditions. The focus is on assessing the efficacy of micronutrients in alleviating symptoms associated with depression and anxiety. For more detailed insights, you can refer to the article in the journal Nutrients.
For the full article visit https://www.mdpi.com/2072-6643/10/2/152
Spedding S. Vitamin D and Depression: A Systematic Review and Meta-Analysis Comparing Studies with and without Biological Flaws. Nutrients. 2014;6(4):1501-1518. doi:10.3390/nu6041501.
A Systematic Review and Meta-Analysis Comparing Studies with and without Biological Flaws
The study “Vitamin D and Depression: A Systematic Review and Meta-Analysis Comparing Studies with and without Biological Flaws” by Spedding, published in Nutrients in 2014, is a systematic review and meta-analysis examining the relationship between vitamin D levels and depression. This research critically evaluates existing studies, distinguishing between those with and without biological flaws, to assess the effect of vitamin D on depression more accurately. For more detailed information, you can refer to the full article in Nutrients.
For the full article visit https://www.mdpi.com/2072-6643/6/4/1501
Parker GB, Brotchie H, Graham RK. Vitamin D and depression. Journal of affective disorders. 2017; 208:56-61.
Vitamin D and depression.
The article “Vitamin D and depression” by Parker GB, Brotchie H, and Graham RK, published in the Journal of Affective Disorders in 2017, examines the potential link between vitamin D levels and depression. It provides insights into the role vitamin D may play in mood regulation and the implications for treating depressive disorders. For a detailed understanding of their findings and conclusions, you can refer to the article in the Journal of Affective Disorders.
For the full article visit https://www.sciencedirect.com/science/article/pii/S0165032716308928
Penckofer S, Kouba J, Byrn M, Ferrans CE. Vitamin D and Depression: Where is all the Sunshine? Issues in mental health nursing. 2010;31(6):385-393. doi:10.3109/01612840903437657.
Vitamin D and Depression: Where is all the Sunshine?
The research paper “Vitamin D and Depression: Where is all the Sunshine?” by Penckofer, Kouba, Byrn, and Ferrans explores the potential link between vitamin D deficiency and depression, as well as other mental health disorders. The study examines various aspects of the relationship between vitamin D levels and mental health, including its connection to seasonal affective disorder (SAD), schizophrenia, and depression.
One of the key findings reported is the impact of vitamin D on mood disorders, especially in women, suggesting that vitamin D could be a significant nutrient for both physical and mental well-being. The paper discusses several studies that have looked into the effects of light therapy and vitamin D supplementation on depressive symptoms. For instance, one study demonstrated a significant decrease in depressive symptoms with vitamin D supplementation compared to phototherapy in participants with SAD.
For the full article visit https://pubmed.ncbi.nlm.nih.gov/20450340/
Penckofer S, Byrn M, Adams W, et al. Vitamin D Supplementation Improves Mood in Women with Type 2 Diabetes. Journal of Diabetes Research. 2017;2017:8232863. doi:10.1155/2017/8232863.
Vitamin D Supplementation Improves Mood in Women with Type 2 Diabetes
The study “Vitamin D Supplementation Improves Mood in Women with Type 2 Diabetes,” conducted by Penckofer, Byrn, Adams, and colleagues, aimed to investigate the impact of vitamin D supplementation on mood and health status in women with Type 2 Diabetes Mellitus (T2DM). The research, published in the Journal of Diabetes Research in 2017, involved 50 women with T2DM who exhibited significant depressive symptoms. All participants received weekly vitamin D supplementation (ergocalciferol, 50,000 IU) for six months.
For the full article visit https://pubmed.ncbi.nlm.nih.gov/29082262/
Li G, Mbuagbaw L, Samaan Z, et al. Efficacy of vitamin D supplementation in depression in adults: a systematic review protocol. Systematic Reviews. 2013;2:64. doi:10.1186/2046-4053-2-64
Efficacy of vitamin D supplementation in depression in adults: a systematic review protocol. Systematic Reviews
The study “Efficacy of Vitamin D Supplementation in Depression in Adults” aimed to assess the effectiveness of vitamin D supplementation in treating depression in adults. This systematic review and meta-analysis focused on comparing the outcomes of oral vitamin D supplementation with a placebo in individuals who were either at risk of depression, exhibited depression symptoms, or had a primary diagnosis of depression.
The research involved a comprehensive search of various databases and sources, including electronic databases, conference proceedings, and gray literature, to identify relevant randomized controlled trials (RCTs). The study included six RCTs with a total of 1203 participants, of which 71 were diagnosed with depression. The majority of the participants were females, accounting for about 72% of the study population.
For the full article visit https://pubmed.ncbi.nlm.nih.gov/23927040/
Bahrami A, Mazloum SR, Maghsoudi S, et al. High Dose Vitamin D Supplementation Is Associated With a Reduction in Depression Score Among Adolescent Girls: A Nine-Week Follow-Up Study. Journal of dietary supplements. 2018; 15(2):173-182
High Dose Vitamin D Supplementation Is Associated With a Reduction in Depression Score Among Adolescent Girls
The study titled “High Dose Vitamin D Supplementation Is Associated With a Reduction in Depression Score Among Adolescent Girls: A Nine-Week Follow-Up Study,” conducted by Bahrami A, Mazloum SR, Maghsoudi S, et al., explored the effects of high-dose vitamin D supplementation on depression in adolescent girls. This research involved administering a weekly dose of 50,000 IU of vitamin D_3 to 940 adolescent girls for a duration of nine weeks. The study aimed to evaluate the effectiveness of this vitamin D supplementation on depression and aggression scores in these girls.
For the full article visit https://pubmed.ncbi.nlm.nih.gov/28406313/
Aucoin M, Cooley K, Anand L, et al. Adjunctive Vitamin D in the treatment of non-remitted depression: Lessons from a failed clinical trial. Complementary therapies in medicine. 2018; 36:38-45
Adjunctive Vitamin D in the treatment of non-remitted depression: Lessons from a failed clinical trial
The study titled “Adjunctive Vitamin D in the treatment of non-remitted depression: Lessons from a failed clinical trial” by Aucoin M, Cooley K, Anand L, et al., published in Complementary Therapies in Medicine in 2018, focused on the role of Vitamin D supplementation in treating patients with non-remitted depression. The study was designed as a randomized, double-blind, placebo-controlled intervention, where participants received a weekly dose of 28,000 IU of Vitamin D3 or a placebo, alongside their current antidepressant medication. The study aimed to observe changes in depression severity, serum vitamin D levels, and safety over eight weeks, followed by a one-month follow-up.
For the full article visit https://pubmed.ncbi.nlm.nih.gov/29458928/
Available from http://jrehabilhealth.com/en/articles/21499.html
At the age of 60, I look and feel better than I ever have in my entire life! Switching my health program and hormone replacement therapy regimen over to Genemedics was one of the best decisions I’ve ever made in my life! Genemedics and Dr George have significantly improved my quality of life and also dramatically improved my overall health. I hav...
Nick Cassavetes ,60 yrs old
Movie Director (“The Notebook”, “John Q”, “Alpha Dog”), Actor and Writer
I am now in my mid-sixties and feel better than I did in my 20’s. Many people have commented that I actually look 20 years younger since I started the program at Genemedics.
Calling Dr. George has proven to be one of the best decisions I have made in my life. Doctors and society convince us that developing various health issues and negative sy...
Pamela Hill ,66 yrs old
Call 800-277-4041 for a Free Consultation
Genemedics® Health Institute is a global premier institute dedicated to revolutionizing health and medicine through healthy lifestyle education, guidance and accountability in harmony with functional medicine. Our physician-supervised health programs are personally customized to help you reach your health and fitness goals while looking and feeling better than ever.
© Copyright Genemedics Health Institute. All Rights Reserved. Privacy Policy.
STEPS AWAY FROM A YOUNGER. HEALTHIER YOU!
Call 800-277-4041 for a Free Consultation
What to expect during your consultation: